Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Thyroid Artery Embolization for the Treatment of Compressive Goiters.

Thyroid Artery Embolization for the Treatment of Compressive Goiters: a Prospective Cohort Study.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Very few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a population ineligible for or refusing standard therapy? This is a prospective interventional cohort study that will allow us to standardize imaging by improving quality data collection and fellow-up to assess the efficacy of TAE for compressive symptoms of nodular goiters. Not only to corroborate current emerging results but clearly define the expected results for this technique.

Who May Be Eligible (Plain English)

Who May Qualify: - Patient with compressive symptoms or significant tracheal or oesophageal compression at risk of causing symptoms attributed to a goiter AND - Ineligible for surgery/ablative treatments or preference for TAE over other treatments AND - TiRADS category 1, 2, 3 or 4 AND - Bethesda categories I or III on 2 different biopsies OR Bethesda II on one biopsy AND - Patient at least 18 years old. Who Should NOT Join This Trial: - Comorbidities precluding endovascular procedure OR - TiRADS category 5 OR - Bethesda categories IV, V, VI on biopsy OR - Refusal of the patient to participate OR - Uncontrolled severe hyperthyroidism OR - Minor patient. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patient with compressive symptoms or significant tracheal or oesophageal compression at risk of causing symptoms attributed to a goiter AND * Ineligible for surgery/ablative treatments or preference for TAE over other treatments AND * TiRADS category 1, 2, 3 or 4 AND * Bethesda categories I or III on 2 different biopsies OR Bethesda II on one biopsy AND * Patient at least 18 years old. Exclusion Criteria: * Comorbidities precluding endovascular procedure OR * TiRADS category 5 OR * Bethesda categories IV, V, VI on biopsy OR * Refusal of the patient to participate OR * Uncontrolled severe hyperthyroidism OR * Minor patient.

Treatments Being Tested

PROCEDURE

Thyroid Artery Embolization

Interruption of blood flow that supplies thyroid nodule using embolization technique.

Locations (1)

Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada